Science Media Centre

Science Media Centre

Expert Reactions

Push for Keytruda funding – Expert reaction

John Kerr posted in on March 1st, 2016.

Public pressure is growing for the Government to fund the melanoma drug Keytruda, listed as ‘low priority’ by drug funding agency PHARMAC. A petition of over 45,000 signatures, calling for the drug to be funded through PHARMAC, is due to be presented to Health Minister Jonathan Coleman on the steps of parliament today. Speaking to […]

Transparency needed in cancer drug markets – Expert reaction

John Kerr posted in on December 4th, 2015.

Experts are calling for greater transparency and fairness in cancer drug pricing, in light of findings revealing discrepancies between Europe, Australia and New Zealand. The results come from a new study published today in the journal Lancet Oncology. The researchers, including a New Zealander, looked at the costs of more than 30 drugs and found […]

Alzheimer’s drug announcement – expert reaction

John Kerr posted in on July 23rd, 2015.

Scientists are cautiously optimistic about new data indicating the drug solanezumab can slow the progression of Alzheimer’s disease – if provided early. The drug’s developer, pharmaceutical company Eli Lilly, this week announced preliminary findings from clinical trials investigating the drug solanezumab. Combining data from several trials, the researchers were able to show that patients who […]

GlaxoSmithKline concedes drug fraud charges

John Kerr posted in on July 3rd, 2012.

Pharmaceutical giant GlaxoSmithKline today announced it will plead guilty to marketing drugs for unapproved uses and failing to report safety data. In what is believed to be the largest ever US healthcare fraud settlement, the company will pay out US$3 billion in criminal fines and civil settlements. The multinational company was charged with violations of […]

Research raises concern over sleeping pills

John Kerr posted in on March 2nd, 2012.

New research has found that several commonly prescribed sleeping pills are associated with a more than fourfold increased risk of death, even among those taking relatively low doses.  However, overseas experts and New Zealand authorities are noting that the link may be more complicated than it appears. The new study, published in the journal BMJ […]

Copyright 2017 Science Media Centre (New Zealand)

Disclaimer | Privacy Policy